Trending...
- CME Webinar- Best Practices for the Management of Individuals with #Cushings Disease
- Beyond Visionary Has Partnered With Heal America To Host INFORM Dallas
- InventHelp Inventor Develops New Toss/Target Game (NJD-2447)
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the 2022 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Wednesday, September 7th. Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).
This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.
More on Jersey Desk
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
Contacts
Press:
Rachel Hooper
rhooper@its.jnj.com
Investors:
Sarah Wood
(732) 524-2617
This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.
More on Jersey Desk
- Tech Luminary Adrian Cockcroft Joins OrionX as Partner
- Nomorobo Assists Urgent FCC and Carrier Efforts to Crack Down on Auto Warranty Scam Robocalls
- OPEX® to Exhibit Warehouse Automation Solutions at UK Event for Supply Chain and Logistics Professionals
- Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
- Diedra Harrison-Greenaway launches new book titled: The Blueprint: A Guide Towards Cannabis Business Ownership
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
Contacts
Press:
Rachel Hooper
rhooper@its.jnj.com
Investors:
Sarah Wood
(732) 524-2617
Filed Under: Business
0 Comments
Latest on Jersey Desk
- Peer-Reviewed Study Shows Measurable Impact on Employee Health and Productivity from Employee Assistance Program
- HWS Announces Top 10 Low Cost Vacation Spots
- World's First Walkie-Talkie Bone Conduction Sport Headphones
- U.S. FDA Approves Additional Indication of NUBEQA® (darolutamide) in Combination with Docetaxel for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Briar Hills Villas Condo Association Names CPM To Manage Suburban Development In West Orange NJ
- Construction Begins on Comprehensive Sedation Dentistry Center in Frederick Maryland
- Kinugawa Onsen Celebrates its 330th Anniversary AND Kawagoe City Celebrates its 100th Anniversary - Both with Fireworks!
- Rook Coffee Brings A Fresh Favorite Back
- Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2022
- VA Center of North County Hosts It's First Annual VANC Fest; an Art, Music and Culinary Experience
- 10 Years in the Making: #LatinaGeeks Celebrates 10th Anniversary with Inaugural Inspirada Awards & Fundraising Gala
- CME Symposium- Fine-Tuning the Management of Patients with #WorseningHeartFailure with Reduced Ejection Fraction
- Alacriti Appoints New Chief Sales Officer and SVP of Faster Payments
- 3i Solutions Announces New Leadership Brings a Customer-Focused Approach
- Cross River Doubles Down on Community Commitment with Spotlight on Financial Literacy
- Perle wins Network Management Product of the Year
- LYNPARZA® (olaparib)Approved in the EU as Adjuvant Treatment for Patients With Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer
- Joseph Federico, Director of NJMET Inc., Announces 2022 STEM Scholarship Recipient
- Help Wanted: Oakland-Based Children Rising Seeks Volunteers to Help Students Overcome COVID-Related Learning Loss
- E3 Forensic Platform Innovates again with Remote Cloud Collection